FIELD: medicine. SUBSTANCE: preparation has human insulin or its analogs and derivative, glycerol and/or mannitol and 5 to 100 mM of halogenide. EFFECT: high chemical stability of insulin preparations at low sodium chloride concentrations. 18 cl, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOHYDRATE-CONTAINING INSULIN PREPARATIONS | 1997 |
|
RU2204411C2 |
| ZINC-FREE INSULIN CRYSTAL FOR APPLICATION IN PULMONARY COMPOSITIONS | 1998 |
|
RU2198181C2 |
| STABLE CONCENTRATED PREPARATIVE INSULIN FORMS FOR DELIVERY BY WAY OF LUNG | 1999 |
|
RU2218935C2 |
| STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2472492C2 |
| INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
| METHOD FOR PREPARATION OF INSULIN COMPOUNDS | 2002 |
|
RU2376379C2 |
| PHARMACEUTICAL PREPARATION CONTAINING CRYSTALLINE INSULIN AND DISSOLVED INSULIN | 2005 |
|
RU2389503C2 |
| TREATING DIABETES MELLITUS BY INSULIN INJECTIONS AS LITTLE AS ONCE DAY | 2009 |
|
RU2540922C2 |
| INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
| METHOD OF CONJUGATING PEPTIDES, MEDIATED BY TRANSGLUTAMINASE | 2005 |
|
RU2385879C2 |
